1. Home
  2. AFYA vs CRVS Comparison

AFYA vs CRVS Comparison

Compare AFYA & CRVS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Afya Limited

AFYA

Afya Limited

HOLD

Current Price

$14.50

Market Cap

1.3B

Sector

Real Estate

ML Signal

HOLD

Logo Corvus Pharmaceuticals Inc.

CRVS

Corvus Pharmaceuticals Inc.

HOLD

Current Price

$13.05

Market Cap

1.0B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
AFYA
CRVS
Founded
1999
2014
Country
Brazil
United States
Employees
N/A
N/A
Industry
Other Consumer Services
Biotechnology: Pharmaceutical Preparations
Sector
Real Estate
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.3B
1.0B
IPO Year
2019
2016

Fundamental Metrics

Financial Performance
Metric
AFYA
CRVS
Price
$14.50
$13.05
Analyst Decision
Hold
Strong Buy
Analyst Count
5
6
Target Price
$17.00
$30.17
AVG Volume (30 Days)
90.3K
1.2M
Earning Date
05-08-2026
05-07-2026
Dividend Yield
4.90%
N/A
EPS Growth
N/A
48.04
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
$10.43
N/A
Revenue Next Year
$7.15
N/A
P/E Ratio
$9.30
N/A
Revenue Growth
N/A
N/A
52 Week Low
$13.00
$3.71
52 Week High
$18.16
$26.95

Technical Indicators

Market Signals
Indicator
AFYA
CRVS
Relative Strength Index (RSI) 57.35 56.38
Support Level $14.24 $12.95
Resistance Level $14.77 $14.00
Average True Range (ATR) 0.44 0.68
MACD 0.03 0.28
Stochastic Oscillator 88.06 96.12

Price Performance

Historical Comparison
AFYA
CRVS

About AFYA Afya Limited

Afya Ltd is a medical education group based in Brazil. Its education portfolio has several courses in addition to Medicine, such as Management, Dentistry, Law, Engineering, Nursing, Psychology, and Accounting Sciences, among others. It has three segments; Undergraduate, deriving key revenue provides educational services through undergraduate courses related to medical school, undergraduate health science and other ex-health undergraduate programs, Continuing Education provides medical education, specialization and graduate courses in medicine, delivered through digital and in-person content; and Medical practice solution provides clinical decision, clinical management and doctor-patient relationships for physicians and provide access, demand and efficiency for the healthcare players.

About CRVS Corvus Pharmaceuticals Inc.

Corvus Pharmaceuticals Inc is a clinical stage biopharmaceutical company developing product candidates that precisely target proteins that are critical to immune cell maturation and function. It believes its proprietary product candidates have broad potential to address immune mediated diseases, inflammatory diseases and cancers. Its product candidate, soquelitinib, is designed to bind specifically to a protein, interleukin 2 inducible T cell kinase (ITK), involved in T cell activation, T cell receptor signaling and T cell differentiation and function. The company operates in one primary business activity and operate as one reportable segment.

Share on Social Networks: